Published in J Clin Oncol on October 01, 1995
Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- MBC | NCT04639986
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. J Natl Cancer Inst (2009) 2.77
History of the Baylor Charles A. Sammons Cancer Center. Proc (Bayl Univ Med Cent) (2003) 2.15
A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer. Pharmacoeconomics (1996) 1.02
Eribulin -- a review of preclinical and clinical studies. Crit Rev Oncol Hematol (2011) 0.94
A unified definition of clinical anthracycline resistance breast cancer. Br J Cancer (2000) 0.87
Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians. Ther Adv Med Oncol (2013) 0.87
Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer. Br J Cancer (2011) 0.83
Breast cancer (metastatic). BMJ Clin Evid (2007) 0.82
A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer. Breast Cancer (Auckl) (2016) 0.79
Chemotherapy for Metastatic Breast Cancer - An Anachronism in the Era of Personalised and Targeted Oncological Therapy? Geburtshilfe Frauenheilkd (2015) 0.79
A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102. Breast Cancer Res Treat (2013) 0.78
Breast cancer (metastatic). BMJ Clin Evid (2010) 0.77
Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer. Br J Cancer (2001) 0.75
A randomized feasibility study of docetaxel versus vinorelbine in advanced breast cancer. Oncologist (2012) 0.75
Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer. Contemp Oncol (Pozn) (2013) 0.75
How clonal are bacteria? Proc Natl Acad Sci U S A (1993) 18.19
Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood (1999) 11.57
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol (2000) 9.76
Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol (1999) 3.62
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol (2005) 3.62
Noninvasive determination of age-related changes in the human arterial pulse. Circulation (1989) 3.08
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol (2001) 3.06
Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst (1997) 2.80
Science and government. Navigating the anthropocene: improving Earth system governance. Science (2012) 2.19
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. J Clin Oncol (1997) 2.17
Hispanic women's breast and cervical cancer knowledge, attitudes, and screening behaviors. Am J Health Promot (2000) 2.11
Third consensus on medical treatment of metastatic breast cancer. Ann Oncol (2009) 1.96
1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96
Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541. Cancer J Sci Am (1997) 1.79
Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol (1991) 1.76
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol (1993) 1.61
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565. J Clin Oncol (2000) 1.56
Treatment of diabetic ketoacidosis (DKA) with 2 different regimens regarding fluid substitution and insulin dosage (0.025 vs. 0.1 units/kg/h). Exp Clin Endocrinol Diabetes (2012) 1.42
Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer (2001) 1.41
[Amniotic fluid embolism: review]. Rev Esp Anestesiol Reanim (1996) 1.39
Second consensus on medical treatment of metastatic breast cancer. Ann Oncol (2006) 1.37
Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25. J Clin Oncol (1999) 1.36
Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group. J Clin Oncol (1999) 1.34
Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer. J Clin Oncol (1996) 1.31
Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications. Dis Colon Rectum (2001) 1.27
Pulse pressure: Is this a clinically useful risk factor? Hypertension (1999) 1.27
Ecological separation and genetic isolation of Neisseria gonorrhoeae and Neisseria meningitidis. Curr Biol (1993) 1.26
Modification of vascular tone using iNOS under the control of a radiation-inducible promoter. Gene Ther (2000) 1.24
Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study. J Clin Oncol (1991) 1.20
Computer image analysis in the diagnosis of melanoma. J Am Acad Dermatol (1994) 1.19
Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone. J Clin Oncol (2001) 1.19
Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. J Clin Oncol (1995) 1.17
Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264. J Clin Oncol (1998) 1.16
Interspecies recombination in nature: a meningococcus that has acquired a gonococcal PIB porin. Mol Microbiol (1995) 1.15
Involving family members in cancer care: focus group considerations of patients and oncological providers. Psychooncology (2000) 1.15
Partitioning methods for multifactorial risk attribution. Stat Methods Med Res (2001) 1.12
Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med (1989) 1.12
Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res (1986) 1.11
A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863. Ann Oncol (2003) 1.11
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Ann Intern Med (1993) 1.11
Computer image analysis of pigmented skin lesions. Melanoma Res (1992) 1.08
A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer. Breast Cancer Res Treat (1983) 1.08
Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med (2008) 1.07
Differences in genetic diversity of nonecapsulated Haemophilus influenzae from various diseases. Microbiology (1997) 1.06
Development of spontaneous activity and mechanosensitivity in axotomized afferent nerve fibers during the first hours after nerve transection in rats. J Neurophysiol (1995) 1.05
A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2. Semin Oncol (1999) 1.05
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol (2001) 1.04
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. Eur J Cancer (2011) 1.04
Alpha-2 adrenergic receptor development in rat CNS: an autoradiographic study. Neuroscience (2004) 1.02
A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion. Int J Obes (Lond) (2006) 0.99
Arginine-, hypoxanthine-, uracil-requiring isolates of Neisseria gonorrhoeae are a clonal lineage with a non-clonal population. Microbiology (1997) 0.98
Sustained-release theophylline therapy for chronic childhood asthma. Pediatrics (1978) 0.97
Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology (1998) 0.97
Rab6c, a new member of the rab gene family, is involved in drug resistance in MCF7/AdrR cells. Gene (2000) 0.96
Pediatric residents' performance of ankle and knee examinations after an educational intervention. Pediatrics (2001) 0.94
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells. J Clin Invest (1996) 0.94
Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART. AIDS Care (2006) 0.94
Ruptured gastroepiploic aneurysm. J Clin Gastroenterol (1994) 0.93
Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. Clin Cancer Res (1998) 0.93
Distribution of sensory properties among axotomized cutaneous C-fibres in adult rats. Neuroscience (1999) 0.93
Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesity. Int J Obes (Lond) (2010) 0.92
Circulating levels of IGFs and IGF binding proteins in human cord serum: relationships to intrauterine growth. Regul Pept (1993) 0.91
Influence of IgG antibody and glycopeptide allergens on the correlation between the radioallergosorbent test (RAST) and skin testing or bronchial challenge with alternaria. Clin Exp Immunol (1975) 0.91
Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840. Ann Oncol (2011) 0.90
Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer. J Immunother (2000) 0.90
Hematoporphyrin-derivative and photoradiation therapy of malignant tumors. Lasers Surg Med (1983) 0.90
Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. J Clin Oncol (2000) 0.90
A comparative assessment of home versus hospital comprehensive treatment for advanced cancer patients. J Clin Oncol (1986) 0.90
A malignant transformation of human cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits altered expressions of growth regulatory factors. Carcinogenesis (1999) 0.90
Genetic testing for susceptibility to breast cancer: findings from women's focus groups. J Womens Health (1997) 0.89
[Dental injuries during general anaesthesia and their forensic consequences (author's transl)]. Anaesthesist (1979) 0.89
Evaluation of colonic neoplasia by flow cytometry of endoscopic biopsies. Am J Gastroenterol (1985) 0.89
The Conduit Artery Functional Endpoint (CAFE) study in ASCOT. J Hum Hypertens (2001) 0.89
Value of morphological parameters for grading of brain swelling. Int J Legal Med (2005) 0.88
Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. Arch Biochem Biophys (1995) 0.88
Myelofibrosis in chronic granulocytic leukemia. Blood (1971) 0.88
Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat. J Neurosci (1998) 0.88
Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study. J Clin Oncol (1988) 0.87
Specificity of fixation loci for homocytotropic antibodies. J Exp Med (1971) 0.87
The involvement of the liver in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol (1980) 0.87
Effects of high dose raloxifene in selected patients with advanced breast carcinoma. Cancer (2000) 0.86
Identification and characterization of a novel murine multigene family containing a PHD-finger-like motif. Biochem Biophys Res Commun (2002) 0.86
Surgery and counterpulsation in cardiogenic shock. Med J Aust (1973) 0.86
Pulse wave analysis in the assessment of patients with left ventricular assist device. J Heart Lung Transplant (2001) 0.86
Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer. J Clin Oncol (1998) 0.86
Effect of transforming growth factor-beta1 on expression of aryl hydrocarbon receptor and genes of Ah gene battery: clues for independent down-regulation in A549 cells. Mol Pharmacol (1997) 0.85
The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer. Breast Cancer Res Treat (2010) 0.85
Abnormal sulphatase activities in two human diseases (metachromatic leucodystrophy and gargoylism). Biochem J (1964) 0.85
Arterial dilation and reduced wave reflection. Benefit of dilevalol in hypertension. Hypertension (1989) 0.85
A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer. Gynecol Oncol (1998) 0.84
Role of nutrition support during induction chemoradiation therapy in esophageal cancer. JPEN J Parenter Enteral Nutr (1998) 0.84
Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience. Clin Trials (2006) 0.84